Roles and contributions of developing country vaccine manufacturers to global vaccine supplies

Suresh Jadhav

Serum Institute of India Pvt Ltd,Hadapsar,Pune,Maharashtra 411028,India

Roles and contributions of developing country vaccine manufacturers to global vaccine supplies

Suresh Jadhav*

Serum Institute of India Pvt Ltd,Hadapsar,Pune,Maharashtra 411028,India

A R T I C L E I N F O

Article history:

Available online 23 November 2015

Vaccine manufacturer

Vaccine supply

Developing Country Vaccine Industry represented by Developing Country Vaccine Manufacturer Network has a track record of manufacturing high quality vaccines.The timely and consistently supplies by DCVMN has led to signifcant progress in expanding the coverage of vaccine globally,resulting in the prevention of more than 2 million death annually. The contributions of industry to polio eradication,meningitis epidemic,pandemic infuenza,MMR vaccination and DPT-based combination vaccines have created a signifcant impact on global health indicators[1].Developing Country Vaccine Industry is now taking steps individually,collectively,and through alliances to develop newer vaccines and contribute to improved global health through increased access,availability,affordability,and adoption of vaccines in developing and developed countries[2].The industry is well positioned today;however,doing this on sustainable basis has its own challenges[1,3].The case study will provide an overview of developing country industry contributions to global vaccine supplies.

Acknowledgements

The author acknowledges and declares that the views presented in this case study do not necessarily represent the views of Serum Institute of India Ltd and/or of DCVMN.

R E F E R E N C E S

[1]Jadhav S,Gautam M,Gairola S.Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.Clin Microbiol Infect 2014;20(Suppl.5):37–44.

[2]Pagliusi S,Leite LC,Datla M,et al.Developing Countries Vaccine Manufacturers Network:doing good by making highquality vaccines affordable for all.Vaccine 2013;31(Suppl. 2):B176–B183.

[3]Pagliusi S,Makhoana M,Datla M,et al.Developing Countries Vaccine Manufacturers Network(DCVMN):engaging to step up for vaccine discovery and access.Meeting report 2012. Vaccine 2013;31(31):3111–3115.

*E-mail address:ssj@seruminstitute.com.

Peer review under responsibility of Shenyang Pharmaceutical University.

http://dx.doi.org/10.1016/j.ajps.2015.10.006

1818-0876/?2016 The Author.Production and hosting by Elsevier B.V.on behalf of Shenyang Pharmaceutical University.This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/4.0/).